Illuvia Sense

ADVANCING SURGICAL SAFETY

Aerobiotix Illuvia Sense Logo

 

SURGICAL AIR SYSTEM

Illuvia Sense® is a surgical air decontamination device with environmental sensing and reporting technologies for reducing risk of surgical site infection and improving overall environmental safety in perioperative environments.

 

  • Reduces SSI risk as demonstrated in clinical studies
  • Creates a safer environment through removal of volatile organic compounds, surgical smoke and bioaerosols
  • Uses internal ultraviolet germicide and HEPA filtration to supplement operating room ventilation
  • Non-turbulent supply of ultraclean air during surgical procedures won’t interfere with existing ventilation
  • Sensing and recording of intraoperative environmental parameters: Particulate, CO2, VOC, door openings
  • Wifi, Bluetooth and Ethernet compatible
  • FDA registered Class II medical device
Watch: How It Works

ADVANCING SURGICAL SAFETY

SURGICAL AIR SYSTEM

Illuvia Sense® is a surgical air decontamination device with environmental sensing and reporting technologies for reducing risk of surgical site infection and improving overall environmental safety in perioperative environments.

 

  • Reduces SSI risk as demonstrated in clinical studies
  • Creates a safer environment through removal of volatile organic compounds, surgical smoke and bioaerosols
  • Uses internal ultraviolet germicide and HEPA filtration to supplement operating room ventilation
  • Non-turbulent supply of ultraclean air during surgical procedures won’t interfere with existing ventilation
  • Sensing and recording of intraoperative environmental parameters: Particulate, CO2, VOC, door openings
  • Wifi, Bluetooth and Ethernet compatible
  • FDA registered Class II medical device
Watch: How it Works

ADVANCING SURGICAL SAFETY

SURGICAL AIR SYSTEM

Illuvia Sense® is a surgical air decontamination device with environmental sensing and reporting technologies for reducing risk of surgical site infection and improving overall environmental safety in perioperative environments.

 

  • Reduces SSI risk as demonstrated in clinical studies
  • Creates a safer environment through removal of volatile organic compounds, surgical smoke and bioaerosols
  • Uses internal ultraviolet germicide and HEPA filtration to supplement operating room ventilation
  • Non-turbulent supply of ultraclean air during surgical procedures won’t interfere with existing ventilation
  • Sensing and recording of intraoperative environmental parameters: Particulate, CO2, VOC, door openings
  • Wifi, Bluetooth and Ethernet compatible
  • FDA registered Class II medical device
Watch: How it Works

Improve Overall
Environmental Safety

Illuvia Sense® runs continuously in operating rooms and does not interrupt existing workflows. Surgical personnel can work in confidence knowing Illuvia Sense is there, quietly working in the background, for their safety and the safety of the patient.

Illuvia Sense is ideally suited for procedures where risk of infection is highest:

  • Orthopedic joint replacement
  • Spinal surgery
  • Implant and reconstructive procedures
  • Long duration procedures (>2 hours)
  • Procedures on immunocompromised patients
  • Procedures on patients with significant comorbidities

Dangerous bacterial bioaerosols arise from OR staff, contacting clothing, gloves, instrumentation and implants. These bacteria are then entrained and carried back to the surgical site, causing wound contamination and surgical site infections.

Dangerous bacterial bioaerosols arise from OR staff, contacting clothing, gloves, instrumentation and implants. These bacteria are then entrained and carried back to the surgical site, causing wound contamination and surgical site infections.

Improve Overall
Environmental Safety

Illuvia Sense® runs continuously in operating rooms and does not interrupt existing workflows. Surgical personnel can work in confidence knowing Illuvia Sense is there, quietly working in the background, for their safety and the safety of the patient.

Illuvia Sense is ideally suited for procedures where risk of infection is highest:

  • Orthopedic joint replacement
  • Spinal surgery
  • Implant and reconstructive procedures
  • Long duration procedures (>2 hours)
  • Procedures on immunocompromised patients
  • Procedures on patients with significant comorbidities

Sometimes What You Can’t See
Poses the Greatest Risk

Even with strict hygiene and quality standards in place, operating room air can be filled with significant levels of bacteria, spores, and viruses which can be transferred from the environment to the surgical site, putting patients and hospital staff at risk.

Illuvia Sense surgical air disinfection system Airborne Bacteria

Airborne Bacteria

Can cause surgical site infection (SSI)1
– On average 250 bacterial colonies per cubic meter of Hospital Air

Illuvia Sense surgical air disinfection system Infectious Aerosols

Infectious Aerosols

SARS-Cov-2, C-Diff, TB, and Staph
– Shed by patients and staff and released through aerosol-generating procedures, and surgical smoke5,6
Illuvia Sense surgical air disinfection system Surgical Smoke Plume

Surgical Smoke Plume

Contains carcinogens like formaldehyde3
– OR staff are exposed to smoke equivalent to approximately 30 cigarettes each day4

Illuvia Sense surgical air disinfection system VOCs

Volatile Organic Compounds

(VOCs) classified as hazardous by OSHA
– Comes from waste anesthetic gases (WAGS), smoke, and other sources7

SIGNIFICANT
HOSPITAL
CHALLENGES

1.7 M

hospital acquired
infections annually9

annual cost of hospital
acquired infections10

$40B

Sometimes What You Can’t See
Poses the Greatest Risk

Even with strict hygiene and quality standards in place, operating room air can be filled with significant levels of bacteria, spores, and viruses which can be transferred from the environment to the surgical site, putting patients and hospital staff at risk.

Illuvia Sense surgical air disinfection system Airborne Bacteria

Airborne Bacteria

Can cause surgical site infection (SSI)1
– On average 250 bacterial colonies per cubic meter of Hospital Air

Illuvia Sense surgical air disinfection system Infectious Aerosols

Infectious Aerosols

SARS-Cov-2, C-Diff, TB, and Staph
– Shed by patients and staff and released through aerosol-generating procedures, and surgical smoke5,6
Illuvia Sense surgical air disinfection system Surgical Smoke Plume

Surgical Smoke Plume

Contains carcinogens like formaldehyde3
– OR staff are exposed to smoke equivalent to approximately 30 cigarettes each day4

Illuvia Sense surgical air disinfection system VOCs

Volatile Organic Compounds

(VOCs) classified as hazardous by OSHA
– Comes from waste anesthetic gases (WAGS), smoke, and other sources7

SIGNIFICANT
HOSPITAL
CHALLENGES

1.7 M

hospital acquired
infections annually9

annual cost of hospital
acquired infections10

$40B

Safe Care Needs
Ultraclean Air

Illuvia Sense® technology is proven to eliminate over 99.9% of airborne bacteria, viruses, and spores.8

Prefiltration: The disposable antibacterial and carbon cartridge captures larger particles ensuring optimum efficiency of the system.

Ultraviolet (UV) Technology: Illuvia Sense utilizes a unique patented UV reaction photolytic chamber to slow and trap pathogens. This results in improved pathogen elimination and room safety over HEPA filtration alone.

HEPA Filtration: The remaining inactive particles are caught in a medical grade HEPA filter, preventing them from returning to environment.

REAL-TIME
INTRAOPERATIVE
ENVIRONMENTAL
DATA

Illuvia Sense® is equipped with integrated sensors that track air quality metrics like particulate count, temperature, humidity, barometric pressure, door opeining count, CO2 levels, and VOCs. The integrated display allows the OR staff to monitor air quality real time, remote access allows for continuous monitoring andreporting.

Safe Care Needs
Ultraclean Air

Illuvia Sense® technology is proven to eliminate over 99.9% of airborne bacteria, viruses, and spores.8

Prefiltration: The disposable antibacterial and carbon cartridge captures larger particles ensuring optimum efficiency of the system.

Ultraviolet (UV) Technology: Illuvia Sense utilizes a unique patented UV reaction photolytic chamber to slow and trap pathogens. This results in improved pathogen elimination and room safety over HEPA filtration alone.

HEPA Filtration: The remaining inactive particles are caught in a medical grade HEPA filter, preventing them from returning to environment.

REAL-TIME
INTRAOPERATIVE
ENVIRONMENTAL
DATA

Illuvia Sense® is equipped with integrated sensors that track air quality metrics like particulate count, temperature, humidity, barometric pressure, door opeining count, CO2 levels, and VOCs. The integrated display allows the OR staff to monitor air quality real time, remote access allows for continuous monitoring andreporting.

Reduce the Contaminants,
Reduce the Risk

To disinfect the operating room air effectively, it’s important to remove contaminated air and replace it with ultraclean air.

Prior to using Illuvia Sense®

Standard vertical flow ventilation flows air downward to create a cleaner air zone around the surgical table. However, established studies have indicated that outer peripheral areas of the OR have significantly less airflow and higher air contamination than the central zone. This contamination arises from frequent foot traffic, door openings and activity. This outer zone can be termed a “dirty donut.”
Contamination in this area can then be transported back to the patient on hands, gowns, instruments or implants.

After using Illuvia Sense®

The Illuvia Sense® technology is designed to increase airflow and decontaminate in this outer zone. The unit outflow is nonturbulent, directed outside of the central zone.

NEARLY A DECADE OF
PEER REVIEWED DATA

 

Significantly reduce total
particle count by up to

73%

Reduce acute changes in
total particle count from
door openings by up to

80%

11. Curtis, G.L., MD, Faour, M., MD, Jawad, Michael, BS, Klika, MS, Barsoum, W.K., MD, Higuera, C.A., MD. Reduction of Particles in the Operating Room Using Ultraviolet Air Disinfection and Recirculation Units. The Journal of Arthroplasty (2017).

Reduce the Contaminants,
Reduce the Risk

To disinfect the operating room air effectively, it’s important to remove contaminated air and replace it with ultraclean air.

Prior to using Illuvia Sense®

Standard vertical flow ventilation flows air downward to create a cleaner air zone around the surgical table. However, established studies have indicated that outer peripheral areas of the OR have significantly less airflow and higher air contamination than the central zone. This contamination arises from frequent foot traffic, door openings and activity. This outer zone can be termed a “dirty donut.”
Contamination in this area can then be transported back to the patient on hands, gowns, instruments or implants.

After using Illuvia Sense®

The Illuvia Sense® technology is designed to increase airflow and decontaminate in this outer zone. The unit outflow is nonturbulent, directed outside of the central zone.

NEARLY A DECADE OF
PEER REVIEWED DATA

 

Significantly reduce total
particle count by up to

73%

Reduce acute changes in
total particle count from
door openings by up to

80%

11. Curtis, G.L., MD, Faour, M., MD, Jawad, Michael, BS, Klika, MS, Barsoum, W.K., MD, Higuera, C.A., MD. Reduction of Particles in the Operating Room Using Ultraviolet Air Disinfection and Recirculation Units. The Journal of Arthroplasty (2017).

Real World Data-driven
Healthcare Solutions

The Illuvia Sense® provides measurable data that enables perioperative teams to proactively manage the amount of airborne contamination in the operating room. Use Illuvia Sense to develop strategies for:

 

  • Reducing risk of surgical site infections, extended length of stay, and readmission
  • Increasing environmental safety for clinicians and patients
surgical air decontamination system Real World Data-driven Healthcare Solutions

Real World Data-driven
Healthcare Solutions

The Illuvia Sense® provides measurable data that enables perioperative teams to proactively manage the amount of airborne contamination in the operating room. Use Illuvia Sense to develop strategies for:

 

  • Reducing risk of surgical site infections, extended length of stay, and readmission
  • Increasing environmental safety for clinicians and patients
surgical air decontamination system Real World Data-driven Healthcare Solutions

Smart Hospital Environments
Create Healthcare Value

Learn more about our complete portfolio of disinfection products by contacting us today.

Aerobiotix surgical air decontamination systems

Smart Hospital Environments
Create Healthcare Value

Learn more about our complete portfolio of disinfection products by contacting us today.

Aerobiotix surgical air decontamination systems
References:
1. Chauveaux D. Preventing surgical-site infections: measures other than antibiotics. Orthopedics & Traumatology. 2015;101(1):S77-83. 2. OM Lidwell, E.J.L. Lowbury, W. Whyte, R. Blowers, S.J. Stanley and D. Lowe. Airborne contamination of wounds in
joint replacement operations: the relationship to sepsis rates. Journal of Hospital Infection (1983) 4, 111-131 3. Bree K, Barnhill S, Rundell W. The Dangers of Electrosurgical Smoke to Operating Room Personnel: A Review. Workplace Health & Safety.
2017;65(11). 4. Hill DS, O’Neill JK, Powell RJ, Oliver DW. Surgical smoke—a health hazard in the operating theatre: a study to quantify exposure and a survey of the use of smoke extractor systems in UK plastic surgery units. J Plast Reconstr Aesthet Surg.
2012; 65(7):911-916. 5. Eames I, Tang JW, Li Y, Wilson P. Airborne transmission of disease in hospitals. Journal of the Royal Society Interface. 2009;6(Suppl 6):S697-S702. 6. Prakash L, Dhar SA, Mushtaq M. COVID-19 in the operating room: a review of
evolving safety protocols. Patient Safety in Surgery. 2020;14. 7. Waste Anesthetic Gases. Occupational Safety and Health Administration. Accessed October 7, 2021. https://www.osha.gov/waste-anesthetic-gases 8. RTI, Research Triangle Park, NC, April
2013. 9. Scott RD II. The Direct Medical Costs of Healthcare-Associated Infections in U.S. Hospitals and the Benefits of Prevention. Center for Disease Control and Prevention; 2009. 10. Economic burden of healthcare-associated infections: an American
perspective – PubMed (nih.gov).

Download GermZone Pro Specs

Download GermZone Pro Specs 📞 +1-888-978-7087

Download AeroCure 200 Specs

Download AeroCure Vac Specs

Download Illuvia®Sense Specs

Download AeroCure 200 Specs 📞 +1-888-978-7087

Download AeroCure Vac Specs 📞 +1-888-978-7087

Download Illuvia®Sense Specs 📞 +1-888-978-7087

JASON-TODD-VP-SALES-AEROBIOTIX

JASON TODD

Sr. Vice President of Global Sales and Marketing

Jason leads our global sales team and brings over 18 years of Medical Device experience to Aerobiotix. Jason has led top performing National and Regional Sales teams, selling disruptive technology in the Cardiovascular space with Getinge, Surgical Robotics at Hansen Medical and most recently in the Biologics space with Axogen. Jason received his Bachelor of Science Degree from the University of Indianapolis.

MELISSA-GIETZEN-VP-GLOBAL-MARKETING-AEROBIOTIX

MELISSA GIETZEN, MBA

Vice President of Global Marketing

Melissa Gietzen, MBA is a highly skilled strategic marketing professional with over 20 years’ experience in the healthcare industry. She has significant expertise in strategic planning, capital budgeting, service improvement projects, and creating strong successful brands in the orthopedic, cardiac & ophthalmology markets. Melissa holds a undergraduate degree in Management and Organization Development and a masters degree in Business Administration.

DAVID KIRSCHMAN, M.D. President and CEO

DAVID KIRSCHMAN, M.D.

President and CEO

The founder and CEO is David Kirschman, M.D., a former physician with extensive experience as CEO, Director, Chief Scientific Officer and operator in the orthopedic and biologic medical device space. Dr. Kirschman holds 55 issued US Patents for a wide range of medical devices. He received his BS in Biological Science cum laude from Colorado State University and M.D. from University of Colorado School of Medicine.

GREGORY CARROLL PH.D. Director Scientific Affairs

GREGORY CARROLL PH.D.

Director Scientific Affairs

Dr. Carroll has extensive experience in ultraviolet and photonic science. Prior to joining Aerobiotix, he led the research and development group at Sunstar Engineering. He has a Ph.D. in chemistry from Columbia University and did his postdoctoral fellowship under Nobel laureate Prof. Ben Feringa at the University of Groningen, Netherlands, and Lawrence Berkeley National Laboratory.

TONY EMBREE Chief Commercial Officer

TONY EMBREE

Chief Commercial Officer

Tony leads our global sales organization and commercialization strategy. Prior joining Aerobiotix, he was Senior Manager of Strategy at Stryker. He has led sales and marketing teams in multiple organizations including SurgiCount Medical, part of Patient Safety Technologies, INC (PSTX) as it expanded from 8 hospitals in 2008 to user base of 330 hospitals at time of acquisition in 2013.

COURTNEY ADAMS, Ph.D. VP of Clinical and Medical Affairs

COURTNEY ADAMS, Ph.D.

VP of Clinical and Medical Affairs

Dr. Adams leads our global clinical research and education initiatives as well as developing key opinion leaders to support our clinical mission. Prior to joining Aerobiotix, she held leading research and medical affairs roles at Biogen, Axogen, and MedPace. Dr. Adams holds Ph.D. in Pharmacology from University of Cincinnati.

ANTHONY DEFALCO Vice President of Engineering

ANTHONY DEFALCO

Vice President of Engineering

Anthony is a topflight medical device product development engineer and leader, experienced in the development and implementation of orthopedic, environmental, and electromechanical systems.

NATHAN UTZ Vice President of Client Services

NATHAN UTZ

Vice President of Strategic Accounts

Nathan brings a high level of commitment to servicing and building client relations. Nathan has previously held leadership roles in the medical device industry.

MICHAEL SCHMITZ Chief Financial Officer

MICHAEL SCHMITZ

Chief Financial Officer

Mr. Schmitz is a highly experienced financial practitioner with financial leadership roles in diverse industries including manufacturing and technology as well as a background in public accounting. He received his BS in accounting, cum laude, from the Miami University of Ohio. Mr. Schmitz is a certified public accountant and certified management accountant.